Immunohistochemical artifact for nitrotyrosine in eosinophils or eosinophil containing tissue.
Immunohistochemical artifacts for nitrotyrosine were investigated in eosinophils with regard to fixatives. Immunoreactivity for nitrotyrosine was revealed in separated eosinophils and in gastric mucosa fixed with periodate, lysine-paraformaldehyde (PLP). The increase in immunoreactivity by PLP was due to periodate itself, a component of PLP. Nitrotyrosine formed by peroxidase using NO2- and H2O2 or by peroxynitrite was not completely inhibited by 100 mM dithionite but the immunoreactivity for nitrotyrosine antibodies by PLP was completely inhibited by 5.7 mM dithionite. Although untreated eosinophils or ovalbumin (OVA) did not show protein tyrosine nitration in a standard Western blot, the treatment of the blotted membrane with PLP increased the reactivities of proteins from eosinophils with anti-nitrotyrosine antibodies. The increase in immunoreactivity of OVA with anti-nitrotyrosine antibodies by PLP did not change with pre-treatment with dithionite but was abolished by treatment with dithionite after PLP fixation. In HPLC assays, periodate did not generate nitrotyrosine from L-tyrosine and aminotyrosine. These results suggest that the treatment of eosinophils or eosinophil-containing tissues with PLP fixative augments the immunoreactivity of nitrotyrosine antibodies with eosinophils due to the formation of epitopes similar to nitrotyrosine by an oxidation reaction of periodate, which evokes an artifact in nitrotyrosine immunohistochemistry.
Ogino
Keiki
K
Department of Environmental and Preventive Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa, Japan. ogino@pub.m.kanazawa-u.ac.jp
Nakajima
Madoka
M
Kodama
Norio
N
Kubo
Masayuki
M
Kimura
Shingo
S
Nagase
Hirohumi
H
Nakamura
Hiroyuki
H
D016477:Artifacts; D002851:Chromatography, High Pressure Liquid; D004227:Dithionite / Q000494:pharmacology*; D004804:Eosinophils / Q000378:metabolism*; D005753:Gastric Mucosa / Q000166:cytology; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D017672:Nitrogen Compounds / Q000378:metabolism; D010047:Ovalbumin / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology; D010084:Oxidation-Reduction; D010504:Periodic Acid / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism*
D017672:Nitrogen Compounds; D016877:Oxidants; D010504:Periodic Acid; D004227:Dithionite; C002744:3-nitrotyrosine; D014443:Tyrosine; D010047:Ovalbumin; D006861:Hydrogen Peroxide; D009195:Peroxidase